Primary and secondary dystonic syndromes: An update

Current Opinion in Neurology

Volumn 26, Issue 4, 2013, Pages 406-412

  Charlesworth, Gavin ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cerebellum; dystonia; genetics; nonmotor; phenotype

Indexed keywords

CERULOPLASMIN; MANGANESE;

ALCOHOLISM; ALPHA CHAIN; AUTOSOMAL DOMINANT INHERITANCE; BLOOD FLOW; BRAIN BLOOD FLOW; CELL CYCLE REGULATION; CERVICAL DYSTONIA; CHOREOATHETOSIS; CLINICAL PRACTICE; DNA SYNTHESIS; DYSTONIC DISORDER; ESSENTIAL TREMOR; FUNCTIONAL NEUROIMAGING; GENERALIZED DYSTONIA; GLOBUS PALLIDUS; HEMIPLEGIA; HEMISPHERIC DOMINANCE; HUMAN; LIVER CIRRHOSIS; MISSENSE MUTATION; MITOCHONDRIAL MEMBRANE; MOLECULAR RECOGNITION; MUTATION; MYOCLONUS DYSTONIA; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; ONSET AGE; OROMANDIBULAR DYSTONIA; PAROXYSMAL KINESIGENIC DYSKINESIA; PATHOGENICITY; PHENOTYPE; PHENOTYPIC VARIATION; PLASTICITY; POLYCYTHEMIA; PRIMARY MOTOR CORTEX; PYRAMIDAL SIGN; QUADRIPLEGIA; QUALITY OF LIFE; REVIEW; SEGMENTAL DYSTONIA; SPASMODIC DYSPHONIA; SUBSTANTIA NIGRA; TRACE METAL BLOOD LEVEL; TRANSCRANIAL MAGNETIC STIMULATION; WILSON DISEASE; X CHROMOSOME;

CEREBELLUM; CHLORIDE CHANNELS; DYSTONIA; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MEMBRANE PROTEINS; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; TUBULIN;

EID: 84880720864     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283633696     Document Type: Review

References (48)

1. Fanh S, Marsden CD, Caine DB. Dystonia 2. Proceedings of the Second International Symposium on Torsion Dystonia. Harriman, New York, 1986.
2. Adv Neurol 1988; 50:1-705.
3. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007; 130:1183-1193. (Pubitemid 47355939)
4. Breakefield XO, Blood AJ, Li Y, et al. The pathophysiological basis of dystonias. Nature Rev Neurosci 2008; 9:222-234. (Pubitemid 351272666)
5. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol 2006; 5:780-790. (Pubitemid 44205514)
6. Bruno MK, Hallett M, Gwinn-Hardy K, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004; 63:2280-2287. (Pubitemid 40024337)
7. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43:1252-1255.
8. Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011; 134:3493-3501.
9. Hedera P, Xiao J, Puschmann A, et al. Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurol 2012; 12:93.
10. Friedman J, Olvera J, Silhavy JL, et al. Mild paroxysmal kinesigenic dyskinesia caused by PRRT2 missense mutation with reduced penetrance. Neurology 2012; 79:946-948.
11. Steinlein OK, Villain M, Korenke C. The PRRT2 mutation c.649dupC is the so far most frequent cause of benign familial infantile convulsions. Seizure 2012; 21:740-742.
12. Cao L, Huang XJ, Zheng L, et al. Identification of a novel PRRT2 mutation in patients with paroxysmal kinesigenic dyskinesias and c.649dupC as a mutation hot-spot. Parkinsonism Relat Disord 2012; 18:704-706.
13. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012; 79:2115-2121.
14. Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012; 1:2-12.
15. Silveira-Moriyama L, Gardiner AR, Meyer E, et al. Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations. Dev Med Child Neurol 2013; 55:327-334.
16. Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012; 90:152-160.
17. Lee HY, Huang Y, Bruneau N, et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012; 1:2-12.
18. Dale RC, Gardiner A, Antony J, Houlden H. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 2012; 54:958-960.
19. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012; 44:1030-1034.
20. Rosewich H, Thiele H, Ohlenbusch A, et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a wholeexome sequencing gene-identification study. Lancet Neurol 2012; 11:764-773.
21. Tenney JR, Schapiro MB. Child neurology: alternating hemiplegia of childhood. Neurology 2010; 74:e57-e59.
22. Peall KJ, Smith DJ, Kurian MA, et al. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 2013; 136:294-303.
23. Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The nonmotor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 2012; 135:1668-1681.
24. Kimmich O, Bradley D, Whelan R, et al. Sporadic adult onset primary torsion dystonia is a genetic disorder by the temporal discrimination test. Brain 2011; 134:2656-2663.
25. Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol 2012; 71:458-469.
26. Klein C, Kö nig IR, Lohmann K. Exome sequencing for gene discovery: time to set standard criteria. Ann Neurol 2012; 72:627-628.
27. Copeland NA, Sercombe HE, Ainscough JF, Coverley D. Ciz1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro. J Cell Sci 2010; 123:1108-1115.
28. Charlesworth G, Plagnol V, Holmstrom KM, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet 2012; 91:1041-1050.
29. Duran C, Qu Z, Osunkoya AO, et al. ANOs 3-7 in the anoctamin/Tmem16 Cl-channel family are intracellular proteins. Am J Physiol Cell Physiol 2012; 302:C482-493.
30. Duran C, Hartzell HC. Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels? Acta Pharmacol Sin 2011; 32:685-692.
31. Lohmann K, Wilcox RA, Winkler S, et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol 2012; doi: 10.1002/ana.23829. [Epub ahead of print].
32. Hersheson J, Mencacci NE, Davis M, et al. Mutations in the autoregulatory domain of b-tubulin 4a cause hereditary dystonia. Ann Neurol 2012; doi: 10.1002/ana.23832. [Epub ahead of print].
33. Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry 1985; 48:218-224. (Pubitemid 15085006)
34. Wilcox RA, Winkler S, Lohmann K, Klein C. Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal. Mov Disord 2011; 26:2404-2408.
35. Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet 2013; 45:88-92.
36. Vemula SR, Puschmann A, Xiao J, et al. Role of Galpha(olf) in familial and sporadic adult-onset primary dystonia. Hum Mol Genet 2013; 22:2510-2519.
37. Zhuang X, Belluscio L, Hen R. G(olf)alpha mediates dopamine D1 receptor signaling. J Neurosci 2000; 20:RC91.
38. Tuschl K, Clayton PT, Gospe SM Jr, et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet 2012; 90:457-466.
39. Quadri M, Federico A, Zhao T, et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 2012; 90:467-477.
40. Stamelou M, Tuschl K, Chong WK, et al. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov Disord 2012; 27:1317-1322.
41. Schneider SA, Bhatia KP. Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J Neural Transm 2012; 120:695-703.
42. Hartig MB, Iuso A, Haack T, et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 2011; 89:543-550.
43. Hogarth P, Gregory A, Kruer MC, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 2013; 80:268-275.
44. Saitsu H, Nishimura T, Muramatsu K, et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 2013; 45:445-449.
45. Haack TB, Hogarth P, Kruer MC, et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet 2012; 91:1144-1149.
46. Quartarone A, Rizzo V, Terranova C, et al. Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain 2009; 132:2871-2877.
47. Schrag AE, Mehta AR, Bhatia KP, et al. The functional neuroimaging correlates of psychogenic versus organic dystonia. Brain 2013; 136:770-781.
48. Sadnicka A, Hoffland BS, Bhatia KP, et al. The cerebellum in dystonia: help or hindrance? Clin Neurophysiol 2012; 123:65-70.